Theraclone Sciences

Of the millions of antibodies produced by the human immune system, Theraclone Sciences’ comprehensive screening technology rapidly identifies the rare few that have evolved to successfully ward off disease. We are working to develop these human monoclonal antibodies as safe and effective therapeutic products.
Company Growth (employees)
Seattle, US
Size (employees)
12 (est)
Theraclone Sciences was founded in 2004 and is headquartered in Seattle, US

Key People/Management at Theraclone Sciences

Clifford J. Stocks

Clifford J. Stocks

Chief Executive Officer & Board of Director
Kristine Swiderek

Kristine Swiderek

Chief Scientific Officer
Russ Hawkinson

Russ Hawkinson

Vice President, Chief Financial Officer
Steven Gillis

Steven Gillis

Executive Chairman and Acting President

Theraclone Sciences Office Locations

Theraclone Sciences has an office in Seattle
Seattle, US (HQ)
300 1124 Columbia St
Show all (1)

Theraclone Sciences Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$58.2 m

Latest funding size

$3.1 m

Time since last funding

almost 3 years


Theraclone Sciences's latest funding round in May 2015 was reported to be $3.1 m. In total, Theraclone Sciences has raised $58.2 m

Theraclone Sciences's Web-traffic and Trends

Theraclone Sciences Company Life and Culture

You may also be interested in